The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.


Time/Date Code Headline Source Impact
14:48 22-Nov-2017 OXP Holding(s) in Company RNS -
09:39 22-Nov-2017 OXP Holding(s) in Company RNS -
16:40 20-Nov-2017 OXP Second Price Monitoring Extn RNS -8.40% Down
16:35 20-Nov-2017 OXP Price Monitoring Extension RNS -8.40% Down
07:00 20-Nov-2017 OXP MPA Advice on OXPzeroT Ibuprofen OTC Opportunity RNS -8.40% Down
07:00 10-Nov-2017 OXP Announcement of demerger RNS +9.92% Up
10:15 02-Oct-2017 OXP MHRA Advice on OXPzeroT Ibuprofen OTC Opportunity RNS -1.89% Down
07:00 25-Sep-2017 OXP Interim Results RNS -11.37% Down
11:38 19-Jun-2017 OXP Result of AGM RNS +1.89% Up
07:00 08-Jun-2017 OXP Further Update re: OXPzero Ibuprofen Programmes RNS +2.55% Up
07:00 09-May-2017 OXP Update regarding OXPzeroTM Ibuprofen Programmes RNS -5.21% Down
09:05 31-Mar-2017 OXP Second Price Monitoring Extn RNS -34.24% Down
09:00 31-Mar-2017 OXP Price Monitoring Extension RNS -34.24% Down
07:00 31-Mar-2017 OXP FDA Feedback on OXPzeroT Ibuprofen Rx Programme RNS -34.24% Down
07:00 10-Mar-2017 OXP Final Results RNS -4.45% Down
07:00 07-Mar-2017 OXP Notice of Results RNS -4.52% Down
07:00 23-Feb-2017 OXP Company Update RNS -4.83% Down
07:00 17-Jan-2017 OXP Company Update RNS +3.31% Up

Price changes are calculated on the basis of the following formula: [ avg(x) - avg(y)] / avg(y) where:
x = instrument's 7 closing prices after the news has been released
y = instrument's latest 7 closing prices before the news was released, including the day of the release of the news

Please note that the news releases are only one of the multiple factors that could have had an impact on the change in the security’s price over the time period analysed by the News Analysis tool. Where data are insufficient the graph does not show any price change and the table below the graph displays a blank “ - “ next to the line indicating the RNS issue.

Company Information
Updated Monthly
Company address Weston House, Bradgate Park View, Chellaston, Derby, DE73 5UJ, United Kingdom
Company website http://www.oxfordpharma...
Market cap(in millions)* £ 15.07
Listing/Admission to trading 12 Feb 2010
Trading service SETSqx
Market AIM
Listing category -
*The market capitalisation of companies reflects the London listed element only. These figures are approximate and are updated monthly.

Trading Information
FTSE index FTSE AIM All-Share,FTSE AIM All-Share - Health Care
FTSE sector Pharmaceuticals & Biotechnology
FTSE sub-sector Pharmaceuticals
Country of share register GB
Segment ASQ1
MiFID Status MTF
Exchange market size 75,000
ISIN number GB00B3LXPB43

OXFORD PHARM GP share news analysis (OXP)